C

ResMed Inc. RMD

$218.27 -$1.31-0.60% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

ResMed Inc. is a medical technology company focused on sleep-disordered breathing, respiratory care, and digital health solutions. The company develops and sells cloud-connected medical devices, software platforms, and out-of-hospital care technologies primarily used to treat obstructive sleep apnea, chronic obstructive pulmonary disease (COPD), neuromuscular disease, and other chronic respiratory conditions. ResMed operates within the broader healthcare equipment, digital health, and software-enabled medical services industries. Its principal revenue drivers include positive airway pressure (PAP) devices, masks and accessories, respiratory care products, and software-as-a-service offerings for healthcare providers and residential care operators.

The company serves sleep clinics, hospitals, durable medical equipment providers, home healthcare providers, residential care facilities, and patients directly across multiple global markets. ResMed’s strategic positioning is tied to its integrated ecosystem of hardware, cloud connectivity, and patient-management software, supported by large-scale data analytics through its digital health platforms. Founded in 1989 and headquartered in San Diego, California, ResMed evolved from a sleep therapy device manufacturer into a broader digital health and connected-care company through product development and acquisitions, including the expansion of its software business through acquisitions such as Brightree, MatrixCare, and MEDIFOX DAN.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Thursday, August 13, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Oct 26 and 30 (est)

Price History

Loading...
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)

Corporate Info

Phone Number
858-836-5000
Address
9001 Spectrum Center Boulevard
San Diego, CA 92123
Country
Year Founded

Headlines

9/10/2026 - Seeking Alpha - Long Ideas